SI1095941T1 - Postopek in kristalne oblike 2-metil-tieno-benzodiazepina - Google Patents

Postopek in kristalne oblike 2-metil-tieno-benzodiazepina

Info

Publication number
SI1095941T1
SI1095941T1 SI9630636T SI9630636T SI1095941T1 SI 1095941 T1 SI1095941 T1 SI 1095941T1 SI 9630636 T SI9630636 T SI 9630636T SI 9630636 T SI9630636 T SI 9630636T SI 1095941 T1 SI1095941 T1 SI 1095941T1
Authority
SI
Slovenia
Prior art keywords
benzodiazepine
thieno
methyl
crystal forms
crystal
Prior art date
Application number
SI9630636T
Other languages
English (en)
Inventor
Charles Arthur Bunnell
Barry Arnold Hendriksen
Samuel Dean Larsen
Original Assignee
Eli Lilly & Company
Eli Lilly And Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23621056&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1095941(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly & Company, Eli Lilly And Company Limited filed Critical Eli Lilly & Company
Publication of SI1095941T1 publication Critical patent/SI1095941T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
SI9630636T 1995-03-24 1996-03-22 Postopek in kristalne oblike 2-metil-tieno-benzodiazepina SI1095941T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40956695A 1995-03-24 1995-03-24
EP00203573A EP1095941B1 (en) 1995-03-24 1996-03-22 Process and crystal forms of 2-methyl-thieno-benzodiazepine

Publications (1)

Publication Number Publication Date
SI1095941T1 true SI1095941T1 (sl) 2003-12-31

Family

ID=23621056

Family Applications (4)

Application Number Title Priority Date Filing Date
SI9630743T SI1445259T1 (sl) 1995-03-24 1996-03-22 Uporaba kristalnih oblik 2-metil-tienobenzodiazepina
SI9630636T SI1095941T1 (sl) 1995-03-24 1996-03-22 Postopek in kristalne oblike 2-metil-tieno-benzodiazepina
SI9620040A SI9620040B (sl) 1995-03-24 1996-03-22 Postopek in kristalne oblike 2-metil-tieno-benzodiazepina
SI9630345T SI0733635T1 (sl) 1995-03-24 1996-03-22 Kristalna oblika tieno(2,3-b)(1,5) benzodiazepinskega derivata in postopek za njegovo pripravo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI9630743T SI1445259T1 (sl) 1995-03-24 1996-03-22 Uporaba kristalnih oblik 2-metil-tienobenzodiazepina

Family Applications After (2)

Application Number Title Priority Date Filing Date
SI9620040A SI9620040B (sl) 1995-03-24 1996-03-22 Postopek in kristalne oblike 2-metil-tieno-benzodiazepina
SI9630345T SI0733635T1 (sl) 1995-03-24 1996-03-22 Kristalna oblika tieno(2,3-b)(1,5) benzodiazepinskega derivata in postopek za njegovo pripravo

Country Status (49)

Country Link
US (1) US5736541A (sl)
EP (3) EP0733635B1 (sl)
JP (1) JPH11502535A (sl)
KR (1) KR100399688B1 (sl)
CN (1) CN1065536C (sl)
AP (1) AP828A (sl)
AR (2) AR010448A1 (sl)
AT (4) ATE204280T1 (sl)
AU (1) AU706471B2 (sl)
BG (1) BG62619B1 (sl)
BR (1) BR9607790A (sl)
CA (1) CA2214005C (sl)
CH (1) CH690579A5 (sl)
CO (1) CO4650278A1 (sl)
CZ (1) CZ292688B6 (sl)
DE (4) DE69630324T2 (sl)
DK (4) DK1445259T3 (sl)
EA (1) EA000149B1 (sl)
EE (1) EE03489B1 (sl)
EG (1) EG23659A (sl)
ES (3) ES2208220T3 (sl)
FI (1) FI973750A (sl)
GB (1) GB2313835B (sl)
HK (1) HK1013988A1 (sl)
HU (1) HU224989B1 (sl)
IL (1) IL117610A (sl)
IS (1) IS1896B (sl)
LT (1) LT4349B (sl)
LU (1) LU90096B1 (sl)
LV (1) LV12018B (sl)
MY (1) MY114701A (sl)
NO (1) NO314663B1 (sl)
NZ (1) NZ306110A (sl)
OA (1) OA10510A (sl)
PA (1) PA8353701A1 (sl)
PE (1) PE44897A1 (sl)
PL (1) PL183723B1 (sl)
PT (3) PT733635E (sl)
RO (1) RO118872B1 (sl)
SE (1) SE9703205D0 (sl)
SI (4) SI1445259T1 (sl)
SK (1) SK284143B6 (sl)
SV (1) SV1996000031A (sl)
TR (1) TR199701017T1 (sl)
TW (2) TW513432B (sl)
UA (1) UA44765C2 (sl)
WO (1) WO1996030375A1 (sl)
YU (1) YU49478B (sl)
ZA (2) ZA962342B (sl)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
EP0852496A4 (en) * 1995-09-29 1998-11-11 Lilly Co Eli METHOD FOR TREATING CHRONIC ICT
UA57727C2 (uk) * 1996-03-11 2003-07-15 Елі Ліллі Енд Компані Спосіб лікування надмірної агресивності
WO1997035585A1 (en) * 1996-03-25 1997-10-02 Eli Lilly And Company Anesthetic method
US6258807B1 (en) * 1996-03-25 2001-07-10 Eli Lilly And Company Method for treating pain
NZ332039A (en) * 1996-03-25 2000-06-23 Lilly Co Eli Method for treating pain using olanzapine and NSAIDs
KR20000004966A (ko) * 1996-03-25 2000-01-25 피터 지. 스트링거 편두통 치료 방법
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
TR199900639T2 (xx) * 1996-09-23 1999-06-21 Eli Lilly And Company Olanzapin dihidrat D.
ZA982917B (en) * 1997-04-15 1999-10-06 Lilly Co Eli Method for treating cerebral focal stroke.
WO1998046596A1 (en) * 1997-04-15 1998-10-22 Eli Lilly And Company Method for providing neuro-protective effects
DK1155696T3 (da) * 1997-04-15 2004-07-12 Lilly Co Eli Anvendelse af olanzapin til fremstillingen af et medikament til neurobeskyttelse
US20030022889A1 (en) * 1997-04-15 2003-01-30 Bymaster Franklin P. Method for providing neuro-protective effects
USRE43932E1 (en) 1997-07-18 2013-01-15 Novartis Ag Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
US6617321B2 (en) 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
GEP20094818B (en) * 1998-09-30 2009-11-10 Lilly Co Eli 2-methyl-thieno-benzodiaze-pine formulation
FR2802101B1 (fr) 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
US6348458B1 (en) 1999-12-28 2002-02-19 U & I Pharmaceuticals Ltd. Polymorphic forms of olanzapine
ES2240215T3 (es) * 1999-12-28 2005-10-16 Cipla Limited Nuevas formas polimorfas de olanzapina.
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
HUP0300875A3 (en) * 2000-08-31 2005-09-28 Reddy S Lab Ltd Hyderabad Dr Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
WO2002019998A2 (en) * 2000-09-08 2002-03-14 Eli Lilly And Company A method of treating weight gain associated with atypical antipsychotic use
US6740753B2 (en) * 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
CA2464306A1 (en) * 2001-10-29 2003-05-08 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
AU2002367119A1 (en) 2001-12-24 2003-07-15 Sun Pharmaceutical Industries Limited Crystalline form I of 2-methyl-4-(4-methyl-1-piperazinyl) 10H thieno [2,3-b][1,5]benzodiazepine
US20050025791A1 (en) * 2002-06-21 2005-02-03 Julius Remenar Pharmaceutical compositions with improved dissolution
WO2004089313A2 (en) * 2003-04-01 2004-10-21 Transform Pharmaceuticals, Inc. Novel olanzapine forms and related methods of treatment
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
AU2003213719A1 (en) * 2002-03-01 2003-09-16 Regents Of The University Of Michigan Multiple-component solid phases containing at least one active pharmaceutical ingredient
PL196814B1 (pl) 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
EP1513846B1 (en) 2002-05-31 2011-03-02 Sandoz Ag Process of preparation of olanzapine form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
PL202856B1 (pl) * 2002-12-20 2009-07-31 Adamed Spo & Lstrok Ka Z Ogran Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny
EP1575962A1 (en) * 2002-12-24 2005-09-21 Teva Pharmaceutical Industries Limited Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US20060135547A1 (en) * 2003-03-12 2006-06-22 Toth Zoltan G Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
EP1507774A1 (en) * 2003-03-12 2005-02-23 Biogal Gyogyszergyar Rt. Processes for preparation of polymorphic forms of desloratadine
GB0314149D0 (en) * 2003-06-18 2003-07-23 Generics Uk Ltd Novel amorphous forms
GB0326148D0 (en) 2003-11-10 2003-12-17 Lilly Co Eli Morpholine derivatives
US20070148218A1 (en) * 2003-11-18 2007-06-28 Gordon Ryan D Olanzapine containing transdermal drug delivery compositions
JP2007515428A (ja) * 2003-12-22 2007-06-14 テバ ファーマシューティカル インダストリーズ リミティド オランザピンの合成方法
US20050272720A1 (en) * 2004-01-27 2005-12-08 Rolf Keltjens Process for making olanzapine Form I
WO2005070938A1 (en) 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
JP5324098B2 (ja) * 2004-11-16 2013-10-23 アルケルメス ファーマ アイルランド リミテッド 注射可能なナノ粒子のオランザピン製剤
PL1838716T3 (pl) 2005-01-05 2011-09-30 Lilly Co Eli Dihydrat embonianu olanzapiny
CZ200563A3 (cs) * 2005-02-02 2006-10-11 Zentiva, A. S. Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
AR053562A1 (es) * 2005-03-21 2007-05-09 Reddys Lab Ltd Dr Proceso para la preparacion de la forma i cristalina de olanzapina
US20070021605A1 (en) * 2005-07-20 2007-01-25 Rolf Keltjens Process and composition for making olanzapine form i
WO2007020080A1 (en) * 2005-08-17 2007-02-22 Synthon B.V. A process for making olanzapine form i
GB0522474D0 (en) 2005-11-03 2005-12-14 Actavis Group A pharmaceutical formulation
HUP0501046A2 (en) * 2005-11-11 2007-08-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of olanzapine
US8721202B2 (en) 2005-12-08 2014-05-13 Ncr Corporation Two-sided thermal print switch
US8367580B2 (en) 2006-03-07 2013-02-05 Ncr Corporation Dual-sided thermal security features
US8222184B2 (en) 2006-03-07 2012-07-17 Ncr Corporation UV and thermal guard
ES2279715B1 (es) 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
WO2007134845A2 (en) * 2006-05-18 2007-11-29 Synthon B.V. Olanzapine pharmaceutical composition
US20080138409A1 (en) * 2006-09-29 2008-06-12 Osinga Niels J Olanzapine pharmaceutical composition
US7718649B1 (en) 2006-11-10 2010-05-18 Pisgah Labs, Inc. Physical states of a pharmaceutical drug substance
US8039461B1 (en) 2006-11-10 2011-10-18 Pisgah Laboratories, Inc. Physical states of a pharmaceutical drug substance
PL381564A1 (pl) 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
US9056488B2 (en) 2007-07-12 2015-06-16 Ncr Corporation Two-side thermal printer
US8883863B1 (en) 2008-04-03 2014-11-11 Pisgah Laboratories, Inc. Safety of psuedoephedrine drug products
CN101735239B (zh) * 2008-11-06 2011-08-31 齐鲁制药有限公司 一种无水奥氮平晶型ii的制备方法
EP2292624A1 (en) 2009-07-20 2011-03-09 LEK Pharmaceuticals d.d. Process for the purification of olanzapine
NZ606730A (en) 2010-08-23 2015-05-29 Alkermes Pharma Ireland Ltd Methods for treating antipsychotic-induced weight gain
CN102093386B (zh) * 2011-01-05 2016-06-01 浙江华海药业股份有限公司 一种制备奥兰扎平晶型ⅱ的方法
WO2012153347A2 (en) 2011-05-04 2012-11-15 Zentiva K.S. Oral pharmaceutical composition of olanzapine form 1
ES2926662T3 (es) 2012-08-21 2022-10-27 Janssen Pharmaceutica Nv Anticuerpos contra haptenos de risperidona y uso de los mismos
CN107253993B (zh) 2012-08-21 2021-10-22 詹森药业有限公司 奥氮平的抗体及其用途
TR201910347T4 (tr) 2012-08-21 2019-07-22 Janssen Pharmaceutica Nv Olanzapin haptenlerine yönelik antikorlar ve bunların kullanımı.
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
CN103848847B (zh) * 2012-12-04 2018-02-06 广东东阳光药业有限公司 一种改进制备奥氮平及其晶型ii的方法
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法
CN103145731B (zh) * 2013-02-26 2014-02-19 江苏豪森药业股份有限公司 奥氮平晶型及其制备方法和用途
WO2023139531A1 (en) 2022-01-20 2023-07-27 Teva Pharmaceuticals International Gmbh Olanzapine, compositions thereof and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115568A (en) * 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) 1977-07-20 1981-03-10 George K. E. Gregory Packages
US4237279A (en) * 1979-07-27 1980-12-02 Eli Lilly And Company Crystalline 3-hydroxycephalosporin solvates
IE53696B1 (en) 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5039540A (en) 1989-08-14 1991-08-13 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
AU668159B2 (en) * 1992-05-29 1996-04-26 Lilly Industries Limited Pharmaceutical compounds
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
HUP9802824A2 (hu) 1999-06-28
SE9703205L (sv) 1997-09-05
IL117610A0 (en) 1996-07-23
DE69630324D1 (de) 2003-11-13
SI9620040B (sl) 2002-02-28
SE9703205D0 (sv) 1997-09-05
TR199701017T1 (xx) 1998-01-21
YU49478B (sh) 2006-05-25
NO974365L (no) 1997-09-22
ATE251627T1 (de) 2003-10-15
GB9719819D0 (en) 1997-11-19
OA10510A (en) 2002-04-24
CZ292688B6 (cs) 2003-11-12
EP1095941A1 (en) 2001-05-02
FI973750A0 (fi) 1997-09-22
CO4650278A1 (es) 1998-09-03
LV12018B (en) 1998-09-20
HUP9802824A3 (en) 2000-01-28
PL183723B1 (pl) 2002-07-31
EA000149B1 (ru) 1998-10-29
NZ306110A (en) 1998-09-24
PT733635E (pt) 2001-12-28
IS4564A (is) 1997-09-22
LV12018A (lv) 1998-04-20
DK1095941T3 (da) 2004-02-16
PA8353701A1 (es) 1998-09-18
PT1445259E (pt) 2006-10-31
JPH11502535A (ja) 1999-03-02
CZ300097A3 (en) 1997-12-17
TW513432B (en) 2002-12-11
ZA962342B (en) 1997-09-22
AT406771B (de) 2000-08-25
EP1445259B1 (en) 2006-06-28
EP1095941B1 (en) 2003-10-08
IS1896B (is) 2003-10-20
GB2313835B (en) 1998-09-16
PT1095941E (pt) 2004-02-27
ATA902196A (de) 2000-01-15
BR9607790A (pt) 1998-07-07
MY114701A (en) 2002-12-31
ES2208220T3 (es) 2004-06-16
FI973750A (fi) 1997-09-22
IL117610A (en) 2001-08-26
SK121897A3 (en) 1998-03-04
AU5427996A (en) 1996-10-16
EE03489B1 (et) 2001-08-15
ZA962344B (en) 1997-09-22
AP828A (en) 2000-04-28
CA2214005A1 (en) 1996-10-03
EA199700262A1 (ru) 1998-02-26
KR19980703188A (ko) 1998-10-15
DE19681286T1 (de) 1998-04-02
US5736541A (en) 1998-04-07
LU90096B1 (fr) 1997-07-22
DK108997A (da) 1997-11-12
DK1445259T3 (da) 2006-10-16
CA2214005C (en) 2001-07-03
NO314663B1 (no) 2003-04-28
GB2313835A (en) 1997-12-10
UA44765C2 (uk) 2002-03-15
SI9620040A (sl) 1998-06-30
SI0733635T1 (sl) 2002-06-30
NO974365D0 (no) 1997-09-22
WO1996030375A1 (en) 1996-10-03
EE9700232A (et) 1998-04-15
DE69630324T2 (de) 2004-07-29
HU224989B1 (en) 2006-05-29
DE69636313D1 (de) 2006-08-10
DE69614426D1 (de) 2001-09-20
SV1996000031A (es) 1998-03-27
CH690579A5 (de) 2000-10-31
PL322501A1 (en) 1998-02-02
PE44897A1 (es) 1997-10-22
AP9701065A0 (en) 1997-10-31
AR010448A1 (es) 2000-06-28
MX9707183A (es) 1997-11-29
DK0733635T3 (da) 2001-10-08
CN1065536C (zh) 2001-05-09
EP0733635A1 (en) 1996-09-25
RO118872B1 (ro) 2003-12-30
BG101900A (en) 1999-03-31
ATE331719T1 (de) 2006-07-15
CN1179160A (zh) 1998-04-15
SK284143B6 (sk) 2004-10-05
EP1445259A1 (en) 2004-08-11
LT97148A (en) 1998-01-26
BG62619B1 (bg) 2000-03-31
ATE204280T1 (de) 2001-09-15
DE69614426T2 (de) 2002-05-23
SI1445259T1 (sl) 2006-10-31
EG23659A (en) 2007-03-26
AR002719A1 (es) 1998-04-29
AU706471B2 (en) 1999-06-17
YU17796A (sh) 1999-03-04
LT4349B (lt) 1998-05-25
DE69636313T2 (de) 2007-05-31
ES2159346T3 (es) 2001-10-01
HK1013988A1 (en) 1999-09-17
KR100399688B1 (ko) 2004-02-18
TW442488B (en) 2001-06-23
EP0733635B1 (en) 2001-08-16
ES2266719T3 (es) 2007-03-01

Similar Documents

Publication Publication Date Title
GB2313835B (en) Process and crystal forms of 2-Methyl-Thieno-Benzodiazepine
EP0744634A3 (en) Polarizer and its manufacture
PL326158A1 (en) Frame and method of making same
HUP9901182A3 (en) Closure and method of making same
EP0867531A4 (en) METHOD AND DEVICE FOR PRODUCING SINGLE CRYSTALS
ZA946706B (en) Spheroidal crystal sugar and method of making
GB2303240B (en) Structure and operation method of LCD
EP0761718A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
EP0704876A4 (en) FLAT DISPLAY AND MANUFACTURING METHOD THEREOF
EP0766123A4 (en) OPTICAL DEVICE AND ITS MANUFACTURING METHOD
PL320340A1 (en) Optical lanses and method of making them
EP0825814A4 (en) LIQUID SMOKE WITH REDUCED TEAR AND MANUFACTURING METHOD
GB9516309D0 (en) Novel compounds and process
EP0761721A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
PL325515A1 (en) Pultry egg and method of producing same
EP0761719A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
GB2297575B (en) Reflective block and method of manufacture
EP0761720A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
SG63665A1 (en) Display forming method and display
GB2306039B (en) Light display and method of forming the same
GB2306182B (en) Acoustic material and method of use
GB9512387D0 (en) Ovenized crystal assembly and method of manufacture
GB9504876D0 (en) Compounds and process
AU6754296A (en) Crystal of hydrate and process for preparation thereof
GB9510969D0 (en) Acoustic material and method of use